Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 218328
Company: SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD
Company: SEASONS BIOTECHNOLOGY (TAIZHOU) CO LTD
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SEHIPPY | VORTIOXETINE | 5MG | TABLET; ORALLY DISINTEGRATING | None (Tentative Approval) | None | No | No |
| SEHIPPY | VORTIOXETINE | 10MG | TABLET; ORALLY DISINTEGRATING | None (Tentative Approval) | None | No | No |
| SEHIPPY | VORTIOXETINE | 20MG | TABLET; ORALLY DISINTEGRATING | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 02/16/2024 | ORIG-1 | Tentative Approval | Type 2 - New Active Ingredient and Type 3 - New Dosage Form | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/218328Orig1s000TAltr.pdf |